Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Ursodeoxycholic Acid Versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy: A Multicenter, Controlled, Randomized, Open Trial

NCT07378761 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT07378761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07378761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Ursodeoxycholic Acid Versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy: A Multicenter, Controlled, Randomized, Open Trial
Lead sponsor
University Hospital, Montpellier
Phase
Phase 2
Overall status
Recruiting
Start date
June 25, 2026
Completion date
December 31, 2028
Enrollment
94 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

immune-mediated cholestasis